Position in RGNX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,585,183
+$1,447,760 QoQ
Shares Held
466,209
-5.6% QoQ
Ownership
0.706%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#22
of 163 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Pale Fire Capital SE holds $45,363,888 across 27 Biotechnology names. RGNX ranks #3 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MLYS |
Mineralys Therapeutics, Inc.
|
614,284 | $16,573,382 | |
| 2 | GERN |
Geron Corp
|
5,307,204 | $6,793,221 | |
| 3 | RGNX |
REGENXBIO Inc.
This page
|
466,209 | $5,585,183 | |
| 4 | GUTS |
Fractyl Health, Inc.
|
5,003,237 | $3,972,570 | |
| 5 | SNDX |
Syndax Pharmaceuticals Inc
|
125,550 | $2,744,523 | |
| 6 | SGMT |
Sagimet Biosciences Inc.
|
221,875 | $1,715,093 | |
| 7 | HRTX |
Heron Therapeutics, Inc. /De/
|
2,511,478 | $1,079,935 | |
| 8 | HELP |
Cybin Inc.
|
153,505 | $1,014,668 |
All Filings in RGNX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,585,183 | 466,209 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $4,137,423 | 493,726 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $7,193,174 | 499,526 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,466,549 | 255,601 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $228,615 | 27,846 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $184,798 | 25,846 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $90,603 | 11,721 | Shares | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||